Two-Drug Combo Supercharges Liver Cancer Therapy in Preclinical Study
A preclinical study reports that combining the kinase inhibitor regorafenib with the small-molecule PD-1/PD-L1 inhibitor BMS-1 synergistically suppresses the growth, ...
A preclinical study reports that combining the kinase inhibitor regorafenib with the small-molecule PD-1/PD-L1 inhibitor BMS-1 synergistically suppresses the growth, ...
A new study links CEACAM1 expression and dysregulated SHP-1, LCK, and ZAP70 signaling to the functional exhaustion of follicular cytotoxic ...
A new case report describes how the immunotherapy drug pembrolizumab triggered pemphigoid nodularis, a rare blistering skin disease that initially ...
A new review in the Journal of Translational Medicine details how post-translational modifications such as ubiquitination, phosphorylation, acetylation, and SUMOylation ...
A phase II pilot trial found that the IDO1 inhibitor epacadostat safely reduced kynurenine-to-tryptophan ratios in advanced melanoma patients but ...
A pilot study found that intratumoral injections of the toll-like receptor 7/8 agonist CB101 combined with hypofractionated radiation therapy were ...
A new review details how ultrasound-triggered nanomaterials paired with patient-derived tumor organoids could enable non-invasive, personalized cancer therapy tested on ...
Researchers have replaced the toxic components of a macrophage-directed immunotherapy for Ewing sarcoma with cyclophosphamide and the erythrocyte-sparing antibody lemzoparlimab, ...
Researchers have developed a transformer-based AI model that generates functional T-cell receptor sequences tailored to specific epitopes, with laboratory tests ...
A new review maps how extracellular vesicles drive gastric cancer progression and how engineered versions could become diagnostics and drug ...
© 2025 Scienmag - Science Magazine
© 2025 Scienmag - Science Magazine